Vicente Martinez Selected Research

Vicente Martinez Research Topics

Disease

9	Visceral Pain 06/2011 - 10/2004
5	Pain (Aches) 06/2009 - 03/2008
5	Schizophrenia (Dementia Praecox) 01/2009 - 05/2005
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021 - 03/2008
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2015 - 01/2002
2	Hyperalgesia 02/2009 - 02/2009
2	Cognitive Dysfunction 01/2009 - 10/2007
2	Neurobehavioral Manifestations 10/2008 - 10/2007
2	Heart Failure 03/2007 - 03/2005
2	Left Ventricular Dysfunction 03/2007 - 03/2005
1	Essential Tremor (Essential Tremors) 08/2021
1	Parkinson Disease (Parkinson's Disease) 12/2020
1	Hemifacial Spasm 01/2019
1	Tremor (Tremors) 01/2018
1	Facial Nerve Injuries 01/2018
1	Dysbiosis 03/2015
1	Food Hypersensitivity (Food Allergy) 03/2015
1	Hypoalbuminemia 07/2012
1	Atrophy 07/2012
1	Hepatic Insufficiency 07/2012
1	Hyperbilirubinemia 07/2012
1	Cerebrospinal Fluid Leak 06/2011
1	Paraplegia (Spastic Paraplegia) 06/2011
1	Urinary Incontinence 06/2011
1	Constipation 06/2010
1	Drug-Related Side Effects and Adverse Reactions 06/2010
1	Diarrhea 06/2010
1	Inflammation (Inflammations) 08/2009
1	Nociceptive Pain 02/2009
1	Neuralgia (Stump Neuralgia) 07/2008
1	Cardiomyopathies (Cardiomyopathy) 03/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2005
1	Macular Edema 06/2003
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 06/2003

Drug/Important Bio-Agent (IBA)

3	Cholinergic Agents (Cholinergics)IBA 10/2007 - 05/2005
2	Baclofen FDA LinkGeneric 06/2011 - 02/2009
2	Biomarkers (Surrogate Marker)IBA 06/2010 - 03/2008
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2009 - 02/2009
2	Analgesics (Analgesic Drugs)IBA 02/2009 - 09/2008
2	Pharmaceutical PreparationsIBA 01/2009 - 10/2008
2	GadoliniumIBA 03/2007 - 03/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Rifaximin (L 105)FDA Link 01/2021
1	Dietary ProteinsIBA 03/2015
1	Staphylococcus aureus auR protein (staphylokinase)IBA 07/2012
1	cytotoxic T lymphocyte-specific serine proteaseIBA 07/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2012
1	Alanine Transaminase (SGPT)IBA 07/2012
1	Dextrans (Dextran)FDA Link 08/2009
1	SodiumIBA 08/2009
1	Drinking WaterIBA 08/2009
1	JYL 1421IBA 06/2009
1	Cannabinoid Receptor AgonistsIBA 02/2009
1	RimonabantIBA 02/2009
1	CannabinoidsIBA 02/2009
1	nabiximols (Sativex)IBA 02/2009
1	2,6- di- tert- butyl- 4- (3- hydroxy- 2,2- dimethylpropyl)phenolIBA 02/2009
1	Vasopressins (Vasopressin)IBA 02/2009
1	GABA-B ReceptorsIBA 02/2009
1	GABA-B Receptor AgonistsIBA 02/2009
1	1- (5- chloro- 1- ((2,4- dimethoxyphenyl)sulfonyl)- 3- (2- methoxyphenyl)- 2- oxo- 2,3- dihydro- 1H- indol- 3- yl)- 4- hydroxy- N,N- dimethyl- 2- pyrrolidinecarboxamideIBA 02/2009
1	p-Methoxy-N-methylphenethylamineIBA 12/2008
1	Clozapine (Clozaril)FDA LinkGeneric 10/2008
1	Haloperidol (Haldol)FDA LinkGeneric 10/2008
1	Clonidine (ST 155)FDA LinkGeneric 09/2008
1	Metabotropic Glutamate 5 ReceptorIBA 07/2008
1	SR 48968 (saredutant)IBA 03/2008
1	Aprepitant (Emend)FDA Link 03/2008
1	Therapeutic UsesIBA 03/2008
1	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 03/2008
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2007
1	Citalopram FDA LinkGeneric 09/2007
1	Serotonin (5 Hydroxytryptamine)IBA 09/2007
1	Indicators and Reagents (Reagents)IBA 03/2007
1	UrocortinsIBA 10/2004
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 01/2002

Therapy/Procedure

3	Deep Brain Stimulation 08/2021 - 01/2018
2	Operative Time 01/2018 - 06/2011
1	Microvascular Decompression Surgery 01/2019
1	Analgesia 02/2009
1	Therapeutics 06/2003
1	Vitreoretinal Surgery 06/2003